Spine And Chronic Pain Care P is categorized under Internal Medicine Doctors in Houston, TX and active since 2005.
Spine And Chronic Pain Care P was established in 2005, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Daniel Dao at the company’s single location by writing to 909 Frostwood Drive # 232, Houston, Texas TX 77024 or by phoning (713) 973-9992. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Spine And Chronic Pain Care P |
| Contact Person: | Daniel Dao |
| Address: | 909 Frostwood Drive # 232, Houston, Texas 77024 |
| Phone Number: | (713) 973-9992 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2005 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Spine And Chronic Pain Care P was started in 2005 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Daniel Dao for inquiries that concern Spine And Chronic Pain Care P by calling the company number (713) 973-9992, as your correspondence is most welcome. Additionally, the physical location of the single location of Spine And Chronic Pain Care P can be found at the coordinates 29.779297,-95.547926 as well as the street address 909 Frostwood Drive # 232 in Houston, Texas 77024.
For its online presence, you may visit Spine And Chronic Pain Care P’s website at and engage with its social media outlets through on Twitter and on Facebook.